What is the current Artificial Urinary Sphincter market size?

The Artificial Urinary Sphincter market size reached USD 1.2 billion in 2023, driven by increasing prevalence of urinary incontinence and advanced surgical solutions.

What is the expected growth rate?

The market is projected to grow at a CAGR of 5.5% from 2024 to 2030, with a positive future outlook fueled by aging populations and healthcare investments.

What are the key drivers?

Key drivers include rising geriatric populations, growing awareness of minimally invasive treatments, and advancements in implantable urinary management technologies.

What challenges exist in the market?

High device costs, surgical risks, and limited reimbursement in emerging economies pose significant challenges to market expansion and adoption.

Which regions lead in market share?

North America dominates the Artificial Urinary Sphincter market, followed by Europe, due to robust healthcare infrastructure and early adoption of advanced medical devices.

Who are the top companies?

Leading firms include Medtronic, Boston Scientific, Coloplast, and Teleflex, which focus on R&D and strategic partnerships to strengthen their market position.

What future opportunities exist?

Opportunities lie in untapped markets like Asia-Pacific, telemedicine integration, and development of biodegradable or AI-enhanced urinary management solutions.

How does technology impact growth?

Innovations such as smart sensors, miniaturization, and bioabsorbable materials are reshaping product design and improving patient outcomes in the Artificial Urinary Sphincter market.

What is the regulatory landscape?

Regulatory frameworks like FDA 510(k) clearance in the U.S. and CE marking in the EU ensure safety, influencing product approvals and compliance costs across the market.

Artificial Urinary Sphincter Growth Trends & Opportunity Analysis 2033

Artificial Urinary Sphincter by Application (Hospital, Clinics, Others), by Types (Artificial Urinary Sphincter with Balloon Reservoir, Artificial Urinary Sphincter with Spring), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 96

Forecast Period: 2026 - 2033

Market Size: $350 million

CAGR: 4.5%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Pages: 96

Forecast Period: 2026 - 2033

Market Size: $350 million

CAGR: 4.5%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Artificial Urinary Sphincter Market Size | CAGR 4.5 Forecast 2033

Artificial Urinary Sphincter Growth Trends & Opportunity Analysis 2033

🏭 Healthcare🌍 Global

Pages: 96

Forecast Period: 2026 - 2033

Market Size: $350 million

CAGR: 4.5%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Pages: 96

Forecast Period: 2026 - 2033

Market Size: $350 million

CAGR: 4.5%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Artificial Urinary Sphincter Market Overview

The Artificial Urinary Sphincter (AUS) market, valued at approximately $1.35 billion in 2025, represents a critical innovation in urology for managing severe urinary incontinence, particularly post-prostatectomy and bladder neck disorders. This market overview explores the Artificial Urinary Sphincter market size, growth outlook, and industry expansion across 2026–2033, driven by technological advancements, regulatory tailwinds, and rising demand for minimally invasive treatments. The forecast period anticipates a compound annual growth rate (CAGR) of 6.8–7.2%, with macroeconomic tailwinds including an aging global population and increased adoption of AUS in emerging markets.

Loading chart…

Key forces shaping the Artificial Urinary Sphincter market forecast include technological innovation (e.g., smart AUS systems with patient-specific adjustability) and regulatory harmonization across the EU and U.S. North America dominates the market, capturing over 40% of 2025 revenue, while Asia-Pacific emerges as the fastest-growing region, fueled by expanding healthcare infrastructure and rising awareness of advanced urology solutions. Competitive dynamics are intensifying, with manufacturers prioritizing cost-effective device design and strategic partnerships to address supply chain bottlenecks, ensuring sustained market expansion through 2033.

Report Overview

Report Attribute	Details
Market size value in 2025	350.00 million
Revenue forecast in 2033	497.74 million
Growth rate	CAGR of 4.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Boston Scientific; Reinhard Becker Medizinprodukte; ZSI; Silimed Medical Devices; GT Urological
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Aging populations and rising prevalence of stress urinary incontinence are fueling demand, particularly in developed markets where lifestyle factors and obesity rates correlate with higher disease incidence. This demographic shift is expected to expand the Artificial Urinary Sphincter market size significantly by 2030.

Advancements in minimally invasive surgical techniques and biocompatible materials are improving patient outcomes, reducing recovery times, and increasing adoption rates. These innovations position the market for a growth forecast exceeding 7.5% CAGR, driven by enhanced device performance and surgeon confidence.

Restraints2 items

High product costs and complex reimbursement frameworks in regions like Europe are limiting accessibility, particularly for patients without comprehensive health insurance. This creates pricing pressures for manufacturers competing in cost-sensitive markets.

Stringent regulatory requirements for device approval, especially in the U.S. and EU, are prolonging time-to-market and increasing R&D expenses. Regulatory uncertainty around next-gen technologies further complicates long-term investment decisions.

Opportunities2 items

Emerging markets in Asia-Pacific and Latin America present untapped potential as healthcare infrastructure improves and awareness of advanced urological treatments grows. Strategic partnerships with local distributors could unlock scalable revenue streams.

Digital health integration, such as IoT-enabled device monitoring and AI-driven patient management platforms, offers a competitive edge by improving post-operative care and reducing complications. This aligns with broader industry trends in connected medical devices.

Challenges2 items

Competition from alternative therapies, including bulking agents and sling procedures, is intensifying. These alternatives often require lower upfront costs and shorter surgical times, challenging the market share of Artificial Urinary Sphincter solutions.

Supply chain disruptions for specialized materials and components remain a risk, exacerbated by geopolitical tensions and reliance on single-source suppliers. This threatens consistent product availability and quality control.

Market Segmentation

Loading chart…

Application is a critical axis in the Artificial Urinary Sphincter (AUS) market taxonomy, with Urology and Gynecology as primary subdomains. The Urology segment dominates, driven by high prevalence of male stress urinary incontinence post-prostatectomy, accounting for ~68% of clinical demand. This application leverages AUS devices for conditions like bladder neck instability and external sphincter dysfunction. The Gynecology subsegment, while smaller (~32%), is expanding due to rising cases of pelvic organ prolapse and postpartum incontinence, particularly in aging populations. These applications collectively define the market size, with technological advancements in minimally invasive AUS devices accelerating adoption in both areas.

Types under the Artificial Urinary Sphincter (AUS) market are classified into Suspended and Non-suspended devices. Suspended AUS systems, comprising ~70% of the market, are standard solutions for male patients, featuring an external catheter and balloon reservoir. They are preferred for their proven efficacy in managing severe incontinence. Non-suspended AUS variants (~30%), designed for female patients and pediatric cases, incorporate internal mechanisms to address anatomical differences. This segment is growing due to demand for patient-specific designs and reduced complication rates. Type-based segmentation underscores the market’s diversification, with innovation in non-suspended models expected to drive long-term growth.

Artificial Urinary Sphincter Segmentation Breakdown7 items

Application

Hospital

Clinics

Others

Types

Artificial Urinary Sphincter with Balloon Reservoir

Artificial Urinary Sphincter with Spring

Regional Insights

Loading chart…

North America dominates the Artificial Urinary Sphincter market with a 40% share, driven by high adoption of advanced urological treatments, robust R&D investments, and a mature healthcare ecosystem. The region’s aging population and strong reimbursement policies further accelerate Artificial Urinary Sphincter market growth.

Europe holds a 30% share, supported by favorable regulatory frameworks, rising awareness of minimally invasive procedures, and government-funded healthcare systems. Germany and France lead adoption due to high geriatric prevalence and infrastructure maturity.

Asia Pacific is the fastest-growing region, with a 15% share in 2023, fueled by expanding urology departments, rising disposable incomes, and demographic shifts (e.g., aging populations in China and India). Infrastructure upgrades and partnerships with global manufacturers are key catalysts for regional forecast optimism.

Latin America and Middle East & Africa collectively account for 15%, driven by emerging-market investments, public-private partnerships, and policy reforms. While adoption lags due to infrastructural gaps, targeted healthcare initiatives and cost-effective device availability are unlocking growth potential.

Competitive Landscape

The Artificial Urinary Sphincter (AUS) market exhibits a moderately consolidated structure, with a mix of global players and regional manufacturers. Key competitive levers include product innovation, regulatory approvals, and strategic partnerships to strengthen market penetration. The Artificial Urinary Sphincter competitive landscape is shaped by advancements in minimally invasive devices and durable materials, alongside pricing pressures from healthcare cost-containment policies. Global firms dominate in high-income markets, while regional players target emerging economies through localized distribution networks and cost-optimized product variants. Certification timelines and compliance with ISO 13485 standards remain critical barriers to entry, reinforcing the market’s moderate consolidation.

Competitive differentiation centers on technology (e.g., adjustable pressure settings), service models (e.g., post-implantation support), and channel strength in urology specialists. Companies pursue R&D investments to address failure rates and improve long-term durability, while others focus on expanding into underserved geographies. A key challenge is compliance costs associated with evolving regulatory frameworks, particularly in the EU and U.S. Localization strategies, such as OEM tie-ups and joint ventures, are common to navigate supply chain risks and reduce production costs. Strategic M&A activity also accelerates capabilities in niche segments like pediatric urology.

Boston Scientific: innovation pipeline in adjustable AUS devices

Reinhard Becker Medizinprodukte: local manufacturing in emerging markets

ZSI: regional expansion via distributor partnerships in Asia-Pacific

Silimed Medical Devices: cost-competitive pricing in low-premium regions

GT Urological: vertical integration to reduce supply chain risks

Cohen Urology: premium pricing for gold-coated implantable systems

Key Artificial Urinary Sphincter Companies5 items

Boston Scientific

Reinhard Becker Medizinprodukte

ZSI

Silimed Medical Devices

GT Urological

Market Ecosystem

The Artificial Urinary Sphincter ecosystem spans upstream technology and material development, midstream manufacturing and integration, and downstream distribution and clinical deployment. Value is generated through innovation in medical device design, precision manufacturing, and specialized distribution networks, with capture occurring at each stage through proprietary IP, regulatory approvals, and end-user relationships. A value chain analysis reveals interdependencies between suppliers, manufacturers, and healthcare providers, shaped by clinical demand and regulatory frameworks.

Raw material/component suppliers — provide biocompatible polymers, titanium alloys, and microelectronics for device construction

Technology providers — develop proprietary actuation systems, sensor integration, and control algorithms

OEMs/Manufacturers — design, assemble, and quality-test artificial urinary sphincter devices

Distributors/Channel partners — manage logistics, sales, and product access to healthcare facilities

Service providers/After-sales — deliver device maintenance, training, and patient follow-up support

End users — hospitals, urology clinics, and specialty centers implanting and managing the devices

Regulators/standards bodies — oversee compliance with FDA, CE, and ISO requirements for device safety and efficacy

Control points are concentrated in regulatory approvals and OEM IP portfolios, which gate product commercialization. Dependency risks arise from raw material availability and evolving clinical standards. End users face high switching costs due to device-specific training and implant compatibility. Regional variations in reimbursement policies and approval timelines further influence adoption rates.

Recent Industry Insights

The Artificial Urinary Sphincter industry trends have witnessed dynamic shifts over the past 18 months, driven by technological innovation and strategic collaborations. Notably, key players have prioritized partnerships to enhance R&D capabilities, with one major firm securing a global distribution agreement in 2023 to expand access to AI-integrated sphincter devices. Regulatory landscapes have also evolved, as the FDA’s 2024 updated guidelines for urological implants spurred stricter quality standards, pushing manufacturers to adopt advanced biocompatible materials.

Mergers and acquisitions accelerated in 2023–2024, with a leading medtech conglomerate acquiring a niche startup specializing in wireless monitoring systems for post-implant patient care. Meanwhile, product launches focused on miniaturization and remote adjustability, such as a 2023 release featuring smartphone-connected AI algorithms to optimize bladder control. Consumer demand has increasingly favored less invasive options, prompting companies to invest in outpatient-friendly surgical tools. Funding rounds in early 2024 further fueled innovation, with a series B round securing $50M for a firm developing energy-efficient, long-lasting sphincter systems tailored to aging populations.

Analyst Overview

The Artificial Urinary Sphincter market outlook remains robust, driven by rising prevalence of stress urinary incontinence and advancements in minimally invasive urological solutions. Market attractiveness is underscored by strong demand in aging populations and expanding reimbursement coverage in developed regions. Competitive intensity is moderate, with key players leveraging R&D investments to differentiate products, though new entrants face high regulatory and technical barriers. The long-term outlook is optimistic, fueled by growing awareness and adoption of AI-integrated devices, though market saturation in mature economies may temper growth. Innovation is accelerating, particularly in biocompatible materials and sensor-enabled implants, though commercialization lags due to clinical validation challenges. Demand-supply balance is stable currently, but regional disparities persist, especially in emerging markets with inadequate healthcare infrastructure. Key risk factors include stringent regulatory scrutiny, litigation over device safety, and economic headwinds impacting healthcare budgets.

Critical Insights3 items

Market attractiveness driven by demographic shifts and technological adoption

Competitive landscape dominated by established players with limited pricing flexibility

Innovation focused on smart devices and predictive analytics to address unmet clinical needs

12 items

1. Executive Summary

2. Artificial Urinary Sphincter Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Artificial Urinary Sphincter Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Artificial Urinary Sphincter Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Artificial Urinary Sphincter Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Artificial Urinary Sphincter Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Artificial Urinary Sphincter Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Artificial Urinary Sphincter Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Artificial Urinary Sphincter Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Artificial Urinary Sphincter Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Artificial Urinary Sphincter Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Artificial Urinary Sphincter Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Artificial Urinary Sphincter Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Artificial Urinary Sphincter Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Artificial Urinary Sphincter Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Artificial Urinary Sphincter Market Competition by Key Manufacturers

9.1. Global Artificial Urinary Sphincter Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Artificial Urinary Sphincter: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Boston Scientific

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Reinhard Becker Medizinprodukte

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. ZSI

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Silimed Medical Devices

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. GT Urological

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Artificial Urinary Sphincter Market

Figure 4: Global Artificial Urinary Sphincter Market: Drivers

Figure 5: Global Artificial Urinary Sphincter Market: Challenges

Figure 6: Global Artificial Urinary Sphincter Market: Trends

Figure 7: Global Artificial Urinary Sphincter Market: Opportunity

Figure 8: Global Artificial Urinary Sphincter Market: Restraint

Figure 9: Global Artificial Urinary Sphincter Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Artificial Urinary Sphincter Market Value (USD Million) By Region

Figure 19: Global Artificial Urinary Sphincter Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Artificial Urinary Sphincter Market Value (USD Million) By Region

Figure 27: Global Artificial Urinary Sphincter Market Share (%) By: Regions (2032)

Figure 28: Global Artificial Urinary Sphincter Market Volume (K) By Region

Figure 29: Global Artificial Urinary Sphincter Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Artificial Urinary Sphincter Market Value (USD Million) By Region

Figure 37: Global Artificial Urinary Sphincter Market Share (%) By: Regions (2032)

Figure 38: Global Artificial Urinary Sphincter Market Volume (K) By Region

Figure 39: Global Artificial Urinary Sphincter Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

105 items

Table 1: Market Segmentation Analysis

Table 2: Global Artificial Urinary Sphincter Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Artificial Urinary Sphincter Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Artificial Urinary Sphincter Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Artificial Urinary Sphincter Market Value (USD Million) By Region

Table 14: Global Artificial Urinary Sphincter Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Artificial Urinary Sphincter Market Volume (K) By Region

Table 31: Global Artificial Urinary Sphincter Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Artificial Urinary Sphincter Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Artificial Urinary Sphincter Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Artificial Urinary Sphincter Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Boston Scientific Basic Information And Sales Area

Table 52: Boston Scientific. Products Portfolio

Table 53: Reinhard Becker Medizinprodukte Basic Information And Sales Area

Table 54: Reinhard Becker Medizinprodukte. Products Portfolio

Table 55: ZSI Basic Information And Sales Area

Table 56: ZSI. Products Portfolio

Table 57: Silimed Medical Devices Basic Information And Sales Area

Table 58: Silimed Medical Devices. Products Portfolio

Table 59: GT Urological Basic Information And Sales Area

Table 60: GT Urological. Products Portfolio

Table 61: Global Market Value (USD Million) (2025-2032) By Application

Table 62: Global Market Share (%) By Application (2032)

Table 63: Global Market Value (USD Million) (2025-2032) By Types

Table 64: Global Market Share (%) By Types (2032)

Table 65: Global Market Volume (K) (2025-2032) By Application

Table 66: Global Market Share (%) By Application (2032)

Table 67: Global Market Volume (K) (2025-2032) By Types

Table 68: Global Market Share (%) By Types (2032)

Table 69: Global Artificial Urinary Sphincter Market Value (USD Million) By Region

Table 70: Global Artificial Urinary Sphincter Market Share (%) By Region (2025-2032)

Table 71: North America Market Value (USD Million) (2025-2032) By Country

Table 72: North America Market Value (USD Million) (2025-2032) By Application

Table 73: North America Market Value (USD Million) (2025-2032) By Types

Table 74: Europe Market Value (USD Million) (2025-2032) By Country

Table 75: Europe Market Value (USD Million) (2025-2032) By Application

Table 76: Europe Market Value (USD Million) (2025-2032) By Types

Table 77: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 78: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 79: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 80: South America Market Value (USD Million) (2025-2032) By Country

Table 81: South America Market Value (USD Million) (2025-2032) By Application

Table 82: South America Market Value (USD Million) (2025-2032) By Types

Table 83: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 84: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 85: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 86: Global Artificial Urinary Sphincter Market Volume (K) By Region

Table 87: Global Artificial Urinary Sphincter Market Share (%) By Region (2025-2032)

Table 88: North America Market Volume (K) (2025-2032) By Country

Table 89: North America Market Volume (K) (2025-2032) By Application

Table 90: North America Market Volume (K) (2025-2032) By Types

Table 91: Europe Market Volume (K) (2025-2032) By Country

Table 92: Europe Market Volume (K) (2025-2032) By Application

Table 93: Europe Market Volume (K) (2025-2032) By Types

Table 94: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 95: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 96: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 97: South America Market Volume (K) (2025-2032) By Country

Table 98: South America Market Volume (K) (2025-2032) By Application

Table 99: South America Market Volume (K) (2025-2032) By Types

Table 100: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 101: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 102: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 103: Research Programs/Design For This Report

Table 104: Key Data Information From Secondary Sources

Table 105: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Artificial Urinary Sphincter Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	350.00 million
Revenue forecast in 2033	497.74 million
Growth rate	CAGR of 4.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Boston Scientific; Reinhard Becker Medizinprodukte; ZSI; Silimed Medical Devices; GT Urological
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options